Loading insider details...
Beta
Latest Form 4 (Aug 18, 2026): Grant/Award of 50,000 RYTM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 18, 2026 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/Award | 50,000 | n/a |
| May 18, 2026 | SOLENO THERAPEUTICS INC (SLNO) | Disposition to Issuer | 20,171 | n/a |
| Jan 23, 2026 | SOLENO THERAPEUTICS INC (SLNO) | Grant/Award | 4,100 | n/a |
| Nov 12, 2025 | SOLENO THERAPEUTICS INC (SLNO) | Grant/Award | 16,071 | n/a |
| Nov 20, 2023 | Atara Biotherapeutics, Inc. (ATRA) | Sale | 12,287 | $4.8K |
| Aug 18, 2023 | Atara Biotherapeutics, Inc. (ATRA) | Sale | 3,202 | $5.3K |